Literatur
Haußmann R, Bauer M, Lewitzka U, Müller-Oerlinghausen B (2016) Psychopharmaka zur Behandlung suizidaler Patienten und zur Suizidprävention. Nervenarzt 87:483–487
Gibbons RD, Brown CH, Hur K, Davis JM, Mann JJ (2012) Suicidal thoughts and behavior with antidepressant treatment reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine. Arch Gen Psychiatry 69:580–587
Braun C, Bschor T, Franklin J, Baethge C (2016) Suicides and suicide attempts during long-term treatment with antidepressants: a meta-analysis of 29 placebo-controlled studies including 6934 patients with major depressive disorder. Psychother Psychosom 85:171–179
Lewitzka U, Severus E, Bauer R, Ritter P, Müller-Oerlinghausen B, Bauer M (2015) The suicide prevention effect of lithium: more than 20 years of evidence-a narrative review. Int J Bipolar Disord 3:32
Lauterbach E, Felber W, Müller-Oerlinghausen B, Ahrens B, Bronisch T, Meyer T, Kilb B, Lewitzka U, Hawellek B, Quante A, Richter K, Broocks A, Hohagen F (2008) Adjunctive lithium treatment in the prevention of suicidal behaviour in depressive disorders: a randomised, placebo-controlled, 1‑year trial. Acta Psychiatr Scand 118:469–479
Meltzer HY, Alphs L, Green AI, Altamura AC, Anand R, Bertoldi A, Bourgeois M, Chouinard G, Islam MZ, Kane J, Krishnan R, Lindenmayer JP, Potkin S, International Suicide Prevention Trial Study Group (2003) Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch Gen Psychiatry 60(1):82–91
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
C. Baethge gibt an, dass kein Interessenkonflikt besteht.
Rights and permissions
About this article
Cite this article
Baethge, C. Keine hochwertige Evidenz für Verhinderung von Suiziden durch Antidepressiva und Clozapin. Nervenarzt 88, 309–310 (2017). https://doi.org/10.1007/s00115-016-0209-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00115-016-0209-7